Gilead Sciences (GILD) Tops Q2 EPS by 56c
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $146.12 +1.87%
Financial Fact:
Interest and other income, net: 119M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Interest and other income, net: 119M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of ($6.75), $0.56 better than the analyst estimate of ($7.31). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.4 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
- UBS Upgrades Apollo Tyres (APTY:IN) to Buy
- Sigma Lithium resumes full operations after signing TAC agreement
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
